Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in Southern, Central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 6, 2000, Pages 693-697

  Taylor, W R J ^a   Doan Hanh Nhan, ^a   Nguyen Dieu Thuong, ^a   Tran Thi Uyen, ^a   Fryauff, D J ^a   Gomez Saladin E ^a   Kain, K C ^a   Le Dinh Cong, ^a   Baird, J K ^a  

^a NAMRU 2   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HALOFANTRINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GENOTYPE; HUMAN; IN VIVO STUDY; MALARIA; MALE; PARASITEMIA; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; VIET NAM;

OCEANIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 0034457918     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.693     Document Type: Article

References (36)

1. World malaria situation in 1994
2. Malaria as a re-emerging disease
3. Antimalarial drug resistance: The pace quickens
4. Plasmodium vivax resistant to chloroquine?
5. Vivax malaria resistant to chloroquine: Case reports from Bombay
6. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma)
7. Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America
8. Vivax malaria resistant to treatment and prophylaxis with chloroquine
9. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
10. Diagnosis of resistance to chloroquine by Plasmodium vivax: Timing of recurrence and whole blood chloroquine levels
11. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia
12. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine
13. Chloroquine resistant Plasmodium vivax in transmigration settlements of West Kalimantan
14. Guidelines for the prevention of malaria in travelers from the United Kingdom
15. Single strand conformational polymorphism analysis differentiates P. falciparum treatment failures from re-infections
16. Determination of Plasmodium falciparum treatment failure by fingerprinting with PCR-SSCP
17. Molecular analysis of primary and relapse isolates of P. vivax
18. Resistance of malarial parasites to drugs
19. The microscopic diagnosis of malaria
20. Analysis of filter paper absorbed, finger stick blood samples for chloroquine and its major metabolite using high performance liquid chromatography with fluorescence detection
21. Mathematical model for studying genetic variation in terms of restriction endonucleases
22. Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America
23. Clinical pharmacokinetics of halofantrine
24. Clinical efficacy and pharmakokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients
25. Studies on the chemotherapy of human malariase. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline
26. Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, P. ovale or P. malariae
27. Antimalarial pharmacokinetics and treatment regimes
28. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia
29. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia
30. Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis
31. Treatment of malaria in Viemam with oral artemisinin
32. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria